Results 101 to 110 of about 95,796 (312)

ADENOSINE TRIPHOSPHATE-ADENOSINE MONOPHOSPHATE TRANSPHOSPHORYLASE (MYOKINASE)

, 1957
Lafayette Noda, Stephen A. Kuby
openalex   +1 more source

Effects of Lipolytic and Antilipolytic Substances on Adenosine 3′,5′-Monophosphate Levels in Isolated Fat Cells

, 1968
R.W. Butcher, C. E. Baird, Earl W. Sutherland   +2 more
openalex   +1 more source

Adenosine 3',5'-monophosphate in rat uterus: acute elevation by estrogen.

, 1967
Clara M. Szego, John S. Davis
openalex   +1 more source

ADCY5‐Mosaic Variants: A Diagnosis Not to Be Missed

Movement Disorders Clinical Practice, EarlyView.
Abstract Background An increasing number of ADCY5‐mosaic patients, seemingly with a milder phenotype, are being identified. However, an in‐depth assessment of their clinical characteristics is lacking. Cases We collected and analyzed data from 12 consecutive ADCY5‐mosaic patients diagnosed at our center and 7 cases from the literature; 63% of the ...
Alice Innocenti, Emmanuel Roze, Florence Riant, Marie‐Céline François‐Heude, Bérénice Lecardonnel, Giacomo Garone, Maxime Colmard, Eline Chauvet‐Piat, Anne‐Cécile Chaux, Marie‐Aude Spitz, Beatrice Desnous, Catherine Sarret, Philippe Damier, Thomas Wirth, Mathieu Anheim, Emilie Retailleau, Estelle Conabady, Caroline Dubacq, Oriane Trouillard, Aurélie Méneret, Agathe Roubertie   +20 more
wiley   +1 more source

An Adenosine 3′,5′-Monophosphate-dependent Protein Kinase from Escherichia coli

, 1969
J.F. Kuo, Paul Greengard
openalex   +1 more source

Early‐Onset Movement Disorder Syndrome Caused by Biallelic Variants in PDE1B Encoding Phosphodiesterase 1B

Movement Disorders, EarlyView.
Abstract Background Breakdown of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) in basal ganglia cells through hydrolysis of diesteric bonds, primarily by PDE10A and PDE1B, is essential for normal human movement. While biallelic loss‐of‐function variants in PDE10A are known to cause hyperkinetic movement disorders, the ...
Tomer Poleg, Noam Hadar, Eyal Kristal, Nicola Y. Roberts, Vadim Dolgin, Ilana Aminov, Amit Safran, Nadav Agam, Matan Jean, Ofek Freund, Eamonn G. Sheridan, James A. Poulter, Michelle L. Thompson, Yusra Algoos, Salma Al‐Qahtani, Lama AlAbdi, Sateesh Maddirevula, Verity Hartill, Henry Houlden, Reza Maroofian, Amit Nahum, Ohad S. Birk   +21 more
wiley   +1 more source

Molecular Tools to Study and Control Dopaminergic Neurotransmission With Light

Medicinal Research Reviews, EarlyView.
ABSTRACT Dopaminergic neurotransmission is involved in several important brain functions, such as motor control, learning, reward‐motivated behavior, and emotions. Dysfunctions of dopaminergic system may lead to the development of various neurological and psychiatric disorders, like Parkinson's disease, schizophrenia, depression, and addictions ...
Galyna Maleeva, Carlo Matera, Silvia Roda, Alessio Colleoni, Marco De Amici, Pau Gorostiza   +5 more
wiley   +1 more source

Control of the Metabolism and Lipolytic Effects of Cyclic 3′,5′-Adenosine Monophosphate in Adipose Tissue by Insulin, Methyl Xanthines, and Nicotinic Acid

, 1968
Melvin Blecher, Nancie S. Merlino, J T Ro'Ane   +2 more
openalex   +1 more source

Abnormal regulation of adenosine 3′,5′-monophosphate and corticosterone formation in an adrenocortical carcinoma [PDF]

, 1969
Robert L. Ney, Norman J. Hochella, A. David Smith, R. N. Dexter, R.W. Butcher   +4 more
openalex   +1 more source

Natural Peptides Versus Semaglutide: A Safer Approach to Obesity Management

Medicine Advances, EarlyView.
This paper highlights that while semaglutide is effective for weight loss, it is associated with significant side effects, high cost, and muscle loss. In contrast, natural peptides such as BRP, BPC‐157, and MOTS‐c demonstrate promising anti‐obesity effects with fewer adverse outcomes, improved safety profiles, and potential affordability making them ...
Muhammad Affan Abid, Muhammad Babar Asad, Muhammad Junaid Razzak   +2 more
wiley   +1 more source